Selective activation of JNK1 is necessary for the anti-apoptotic activity of hILP.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 9600909.
- Also identified by PMC identifier 27577.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The balance between the inductive signals and endogenous anti-apoptotic mechanisms determines whether or not programmed cell death occurs. The widely expressed inhibitor of apoptosis gene family includes three closely related mammalian proteins: c-IAP1, c-IAP2, and hILP. The anti-apoptotic properties of these proteins have been linked to caspase inhibition. Here we show that one member of this group, hILP, inhibits interleukin-1beta-converting enzyme-induced apoptosis via a mechanism dependent on the selective activation of c-Jun N-terminal kinase 1. These data demonstrate that apoptosis can be inhibited by an endogenous cellular protein by a mechanism that requires the activation of a single member of the mitogen-activating protein kinase family.
Medical subject headings
- Apoptosis
- Calcium-Calmodulin-Dependent Protein Kinases
- Mitogen-Activated Protein Kinases
- Proteins
- Signal Transduction